vTv Therapeutics (VTVT) Return on Sales Growth (5y) (2019 - 2026)

vTv Therapeutics (VTVT) Return on Sales Growth (5y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 vTv Therapeutics 19.21 Mn 19.21 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 7.00
Sep 30, 2025 -1,347.00
Jun 30, 2025 -317.00
Mar 31, 2025 -452.00
Dec 31, 2024 722.00
Sep 30, 2024 722.00
Jun 30, 2024 -23.00
Mar 31, 2024 -2.00
Sep 30, 2023 -3,068.00
Jun 30, 2023 -2,723.00
Mar 31, 2023 -1,185.00
Dec 31, 2022 -617.00
Sep 30, 2022 810.00
Jun 30, 2022 577.00
Mar 31, 2022 471.00
Dec 31, 2021 -1,203.00
Sep 30, 2021 355.00
Jun 30, 2021 -13.00
Mar 31, 2021 30.00
Dec 31, 2020 -14.00